Harrow, Inc. (HROW)
41.50
+0.85
(+2.09%)
USD |
NASDAQ |
Apr 17, 16:00
41.26
-0.24
(-0.58%)
After-Hours: 06:47
Harrow SG&A Expense (Quarterly) : 43.31M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| Esperion Therapeutics, Inc. | 41.43M |
| Hims & Hers Health, Inc. | 314.21M |
| Corcept Therapeutics, Inc. | 130.24M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |